Business Description
Biohaven Ltd. is a pharmaceutical company based in New Haven, Connecticut, focused on researching and bringing new medicines to patients with immune system disorders, neurological conditions, and cancer. The company has a broad portfolio of drug candidates at various stages of clinical testing, targeting conditions such as Parkinson's disease, epilepsy, rheumatoid arthritis, obesity, and several types of cancer, among others. A number of additional treatments are in earlier stages of research, addressing diseases ranging from type 1 diabetes to hearing disorders.
